AAI-BioLegend Herzenberg Award
This award recognizes exceptional scientific contributions to B cell biology and antibody research in immunology, with recipients presenting their work at the AAI annual meeting.
Funder: American Association of Immunologists
Due Dates (Anticipated): August 2026: Nominations open (projected) | September 2026: Nominations/complete nomination package deadline (projected) | September 2026: Previous-year nomination closing date (historical window: Aug 6—Sep 18) projected as a potential closing date (projected)
Funding Amounts: $5,000 cash prize, complimentary AAI annual meeting registration, and travel support for award lecture (one-time award)
Summary: Recognizes outstanding investigators for exemplary contributions to B cell biology in immunology, with an award lecture at the AAI annual meeting.
Key Information: Nominee and nominator must be Regular AAI members in good standing; self-nominations are not permitted.
Description
This award, established in memory of Leonard A. Herzenberg, Ph.D., honors investigators who have made outstanding contributions to immunology, specifically in B cell biology. Supported by BioLegend, it recognizes achievements related to the development, regulation, genetics, and use of antibodies in both basic and clinical research, including therapeutic applications. The recipient will present their research in an award lecture at the AAI annual meeting and receive a cash prize, complimentary meeting registration, and travel support.
